drugset / Trial / NCT01203774
Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the Hospital
RandomizedCrossoverOpen-labelTreatment
Summary
In this study the investigators would like to test the hypothesis that in diabetic patients discharged from the hospital, SoloSTAR Glargine insulin will be superior to syringe-injected Glargine in terms of diabetes control, compliance, and patient satisfaction and preference. The investigators will test this hypothesis in a randomized, crossover trial.
Timeline
- Start
- 2010-09
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | glargine insulin | Protein / enzyme biologic | 20 iu | — |
| Comparator | glargine insulin | Protein / enzyme biologic | 180 iu | — |